

Descovy is an NRTI combination used for HIV treatment and PrEP. Learn about its uses, dosage, cost, and key facts for 2026.
Descovy (Emtricitabine/Tenofovir Alafenamide) is a prescription medication that combines two nucleoside reverse transcriptase inhibitors (NRTIs) in a single tablet, used for treating HIV-1 and for pre-exposure prophylaxis (PrEP) to help prevent HIV infection.
Whether you've just been prescribed Descovy or you're researching it for the first time, this guide covers everything you need to know — from what it is and how to take it, to who should avoid it and how much it costs.
Descovy is a brand-name medication manufactured by Gilead Sciences. Each tablet contains:
A lower-dose pediatric tablet (120 mg/15 mg) is also available for children weighing 14 kg to less than 25 kg.
Descovy belongs to the NRTI drug class. It is not a controlled substance. There is currently no FDA-approved generic version of Descovy available in the United States as of 2026, though generic versions have been approved in the EU.
To learn how Descovy works at the molecular level, see our article on Descovy's mechanism of action.
Descovy is FDA-approved for two uses:
Descovy is used in combination with other antiretroviral medications to treat HIV-1 infection in adults and pediatric patients weighing at least 14 kg. Important: Descovy alone is not a complete HIV treatment regimen — it must be combined with other antiretrovirals.
Descovy for PrEP is taken daily to reduce the risk of getting HIV through sex in at-risk adults and adolescents weighing at least 35 kg.
Key limitation: Descovy for PrEP is not indicated for individuals at risk from receptive vaginal sex, as its effectiveness has not been evaluated in this population. For those individuals, Truvada or other PrEP options may be more appropriate.
Descovy is taken as one tablet by mouth once daily, with or without food. Here's what you need to know about taking it correctly:
Descovy is not appropriate for everyone. You should not take Descovy if:
You should also use caution and discuss with your doctor if you:
For information on potential drug interactions, read our guide on Descovy drug interactions.
Descovy is expensive. Without insurance, the cash price ranges from $2,200 to $2,944 per month for a 30-tablet supply.
However, many patients pay significantly less — or nothing at all:
For a full breakdown of savings options, see our guide on how to save money on Descovy.
Descovy is a well-established, effective medication for both HIV treatment and prevention. Its improved kidney and bone safety profile compared to older alternatives like Truvada has made it a preferred option for many patients and providers. While the cost can be daunting, insurance coverage, manufacturer programs, and patient assistance make it accessible for most people.
If you've been prescribed Descovy and need to find it, Medfinder can help you locate pharmacies near you that have it in stock. To learn about side effects, check out our Descovy side effects guide.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.